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Abstract
Background: Injury to the peripheral branch of dorsal root ganglia (DRG) neurons prior to injury to the central
nervous system (CNS) DRG branch results in the regeneration of the central branch. The exact mechanism
mediating this regenerative trigger is not fully understood. It has been proposed that following peripheral injury,
the intraganglionic inflammatory response by macrophage cells plays an important role in the pre-conditioning of
injured CNS neurons to regenerate. In this study, we investigated whether the presence of macrophage cells is
crucial for this type of regeneration to occur. We used a clodronate liposome technique to selectively and
temporarily deplete these cells during the conditioning phase of DRG neurons.
Results: Retrograde and anterograde tracing results indicated that in macrophage-depleted animals, the
regenerative trigger characteristic of pre-conditioned DRG neurons was abolished as compared to injury matched-
control animals. In addition, depletion of macrophage cells led to: (i) a reduction in macrophage infiltration into
the CNS compartment even after cellular repopulation, (ii) astrocyte up-regulation at rostral regions and down-
regulation in brain derived neurotrophic factor (BDNF) concentration in the serum.
Conclusion: Activation of macrophage cells in response to the peripheral nerve injury is essential for the enhanced
regeneration of ascending sensory neurons.
Background
Injured axons in the mammalian central nervous system
(CNS), compared to those in the peripheral nervous sys-
tem (PNS), do not regenerate. The limited capacity of
matured CNS axons to regenerate has been attributed
to the presence of an inhibitory barrier formed by mye-
lin and its associated molecules [1], especially when
expressed after injury [2,3]. Consequently, many of the
damaged axons undergo atrophy and form ‘dystrophic
end balls’ indicative of halted attempts at regeneration
[4]. The use of peripheral nerve grafts to circumvent
inhibitory cues in the injured CNS environment have
been successful at stimulating axonal regeneration
[1,5,6] and have provided important evidence for the
intrinsic ability of adult injured neurons to regrow and
remain in a regenerative mode within the CNS.
In dorsal root ganglion (DRG) neurons, injury to the
peripheral branch in the form of a sciatic nerve injury
(SNI) prior to injury to the CNS branch (spinal cord - dor-
sal column cut), has been previously shown to result in
axonal regeneration of centrally projecting ascending
fibres [7]. This is referred to as conditioning of DRG neu-
rons and it demonstrates the regenerative capacity of
injured fibres in the matured CNS. However, the exact
mechanism mediating this regenerative trigger is not fully
understood. It has been proposed that activation of macro-
phage cells, together with satellite cell activation and pro-
liferation within the DRG, as part of the normal PNS
response to injury, might be playing a crucial role [8].
Interestingly, the exogenous application of cAMP (cyc-
lic adenosine monophosphate) to DRGs in vivo can
mimic the regeneration of the injured CNS branch,
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Mechanistically, this regenerative response after cAMP
administration, has been attributed to the blocking and/
or reduction in sensitivity of axons to myelin inhibitors
in the CNS [10]. Elevation in cAMP by priming and/or
exposing neurons in vitro to trophic factors such as
brain derived neurotrophic factor (BDNF) resulted in
neurite outgrowth in the presence of inhibitory mole-
cules such as myelin and myelin-associated glycoprotein
(MAG) [11]. This is important given that endogenous
neurotrophic factors such as BDNF and cilliary neuro-
trophic factor (CNTF) have been shown to be essential
for enhancing regeneration [12-15].
Recently, we and others have demonstrated that after
SNI, there is a robust macrophage response infiltrating
DRGs [16] and even other parts of CNS such as the
spinal cord [17] and optic nerve [18]. In addition,
further evidence from our laboratory indicates that
macrophages can express a number of neurotrophic fac-
tors such as BDNF, NGF, and other neurotrophic cyto-
kines [19]. In this study, we hypothesized that
macrophage cells play a crucial role in the conditioning
and regeneration of the CNS-DRG branch (i.e. afferent
fibres). To test this, we selectively and temporarily
depleted macrophage cells during the conditioning
phase of DRG neurons (i.e. prior to, during and after
SNI) via the intravenous delivery of a liposome-encapsu-
lated clodronate, a technique described to result in
macrophage suicide [20,21]. We found that the temporal
depletion of these cells completely abolished the regen-
erative trigger characteristic of this model and therefore,
we propose a beneficial role of macrophage cells in the
regeneration of pre-conditioned DRG neurons.
Methods
Animals
Adult female Sprague Dawley (SD) rats (10-12 weeks)
were used under the guidelines of the National Health
and Medical Research Council of Australia and
approved by the Animal Welfare Committee of Flinders
University of South Australia.
Treatment Groups
Animals were divided into 2 experimental groups, both
of which received a SNI (day 0) followed by a dorsal
column cut (DCC, day 7). The timing of the CNS injury
relates to the optimal conditioning of DRG neurons,
k n o w nt oo c c u rs e v e nd a y sa f t e rS N I ,r e s u l t i n gi nt h e
maximum amount of CNS regeneration possible [7].
Control animals (n = 10) received intravenous (iv) tail
vein injections of sterile saline alone (2 ml/injection).
Test animals (n = 10) received iv tail vein injections of
liposome-encapsulated clodronate (2 ml/injection). In
both of these two groups sterile saline was administered
as the vehicle during iv delivery and the only difference
between them was the use of liposomes in the treatment
group. Note that control animals did not receive lipo-
some-encapsulating saline given the possibility that lipo-
somes alone may “block macrophage phagocytosis by
saturation and may suppress or activate other macro-
phage functions” [22]. Consequently, this would have
provided inconsistent comparisons between liposome-
treated and control group animals.
Sciatic Nerve Injury (SNI)
For all surgical procedures, the toepinch-reflex test was
used to determine effectiveness of the anaesthetic prior
to surgery using a mixture of ketamine (100 mg/kg) and
xylazine (100 mg/kg) delivered intraperitoneally. Briefly,
a primary longitudinal cut was made on the skin over-
laying the femur of the left hind limb. The incision was
extended proximally and distally exposing the thigh
muscle. Sharp surgical scissors were inserted and
opened into the muscle through the first layer to the
level at which the sciatic nerve runs. After locating the
branching of the sciatic nerve, the nerve was ligated
proximal to its trifurcation and cut below the ligation
site with fine surgical scissors. The wound was sutured
closed using a 6/0 surgical silk suture and animals were
placed into individual cages.
Dorsal Column Cut (DCC)
After laminectomy at T9-T10 and a small incision in the
dura mater, the dorsal columns of the spinal cord were
crushed with iris scissors inserted at a depth of approxi-
mately 1.5-2 mm (marked on the scissors’ tip) [23]. A
sharp scalpel blade was passed through the wound twice
to confirm bilateral DCC [24]. A small piece of gelfoam
was temporarily placed over the lesion site to encourage
blood clotting and the overlaying muscles were sewn
together with a 6/0 surgical suture. The skin was stapled
closed and the animals were returned to their cages.
After surgery, animals were housed separately and
received subcutaneous injections of the analgesic drug
buprenorphine (0.03 mg/kg) for a period of up to 5 days
to alleviate postoperative pain. For all spinal cord
injured animals manual bladder expression was per-
formed two to three times per day and antibiotics were
administered if required [25].
Retrograde Tracer Injection
To investigate the presence of ascending regenerated
fibres in the injured spinal cord (i.e. across the injury
epicentre), a somatic retrograde tracer Fast Blue (FB, 5%
in saline, Sigma) was injected into the dorsal column of
the proximal stump, 3-4 mm rostral from the site of
spinal cord injury (SCI; injection depth 1-1.1 mm, total
volume delivered 0.1 μl). FB was administered 2 weeks
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glass micropipette needle. Note that to alleviate any
pain caused by tracer injections into the spinal cord, all
animals received injections of buprenorphine (0.03 mg/
kg) for up to 3 days after injection.
Anterograde Tracer Injection
To further examine the presence of ascending CNS fibres
regenerating across the SCI epicentre, the anterograde
tracer Biotinylated Dextran Amine (BDA, 10% in saline,
10000 mw, Molecular Probes) was injected into the dor-
s a lc o l u m ni nt h el u m b a rr e g i o no ft h es p i n a lc o r d
[26-28]. BDA was delivered 2 weeks after CNS lesion as
described for retrograde tracing (injection depth 1-1.1
mm, total volume delivered 0.1 μl). All care was taken to
keep tracer injections within the dorsal column of the
spinal cord. Some injected cords were randomly selected
to confirm tracer deposition, however, not all injections
sites were examined and further damage to the cord at
these sites was not investigated in this study.
Liposome Preparation and Administration
Liposomes were prepared according to previous studies
[29-32]. Briefly, 86 mg of egg phosphatidylcholine and 8
mg of cholesterol were dissolved in 5 ml of chloroform
in a round-bottom flask. Chloroform was removed by
using a low-vacuum rotary evaporator at 37°C to form a
thin lipid film around the flask. The lipid was then dis-
persed with 10 ml sterile phosphate buffered saline
(PBS, 0.1 M, pH 7.4) containing 2.5 gm of clodronate
(dichloromethylene-diphosphonate-DMDP, Sigma) and
incubated on a gentle stirrer at room temperature (RT,
2 hrs). After incubation, the suspension was sonicated
(50 Hz) at RT (3 min) and incubated again at RT with
no stirring to allow for liposome formation (2 hrs).
Liposomes were centrifuged at 10,000 g (15 min) at RT
to remove any free clodronate. The remaining pellet was
washed twice in sterile PBS at 20,000 g at RT (30 min)
and resuspended in 4 ml sterile PBS to be used immedi-
ately [29,30,33].
Liposome Administration
For all test animals, liposomal delivery was administered
on three separate occasions, once: i) three days prior to;
ii) immediately after; and iii) four days after SNI. The
specific timing of liposome administration ensured
macrophage depletion commencing 3 days prior to SNI
and ending 3 days after DCC. It is known that macro-
phage cells are depleted within 24 hrs after liposomal
treatment and begin to slowly repopulate approximately
5-7 days after last administration of clodronate (personal
communication with liposome pioneer Dr Nico van
Rooijen, Netherlands). No adverse side effects were
observed in any of the liposome-treated animals.
Perfusion and Cryosectioning
All animals were injected intraperitoneally with 5%
chloral hydrate in distilled water and perfused transcar-
dially with 1% NaNO2/phosphate buffer (PB, 0.1 M, pH
7.4) followed by a 4% paraformaldehyde (PFA)/PB. Per-
fusions were performed 4 weeks after the CNS lesion
with all dissected tissues post-fixed in 4% PFA and cryo-
protected in 30% sucrose/PB at 4°C (48 hrs). Spleens
were cryosectioned at 20 μm( c r o s s - s e c t i o n s ) ,D R Ga t
20 μm (coronal sections) and spinal cords at 40 μm
(longitudinal sections). All specimens were mounted on
2% gelatine-coated glass slides.
Immunohistochemistry (IHC)
For IHC, DRG and spinal cord sections were washed in
0.5% H2O2/50% ethanol at RT (30 min) to quench endo-
genous peroxide activity, rinsed in PBS, followed by three
washes in PBS containing 1% Tween-20 detergent (PBST).
These sections were blocked in 20% normal horse serum
(NHS, 2 hrs) before incubation with primary antibodies at
4°C (48 hrs). The primary antibodies used were: mouse-
anti-rat cluster differentiation 68 (CD68, macrophage,
1:400, Serotec), rabbit-anti-glial fibrillary acidic protein
(GFAP, astrocyte/satellite cells, 1:500, Dako). A combina-
tion of the following secondary antibodies for single and/
or double labelling included: sheep-anti-mouse-cy3-IgG
(1:500, Jackson), donkey-anti-mouse-cy2-IgG (1:500, Jack-
son), donkey-anti-rabbit-488-IgG (1:500, Jackson), sheep-
anti-rabbit-cy3-IgG (1:500, Jackson). The specificity of the
observed IHC procedure was validated by omitting the
primary antibody and/or byu s i n gan o n - i m m u n es e r u m
instead of the primary antibody [24].
Immunoperoxidase Staining
BDA injected tissue was treated in 3% H2O2/100%
methanol at RT (10 min), rehydrated in PBS and thor-
oughly washed in PBST. This was followed by incuba-
tion with streptavidin-HRP conjugated antibody (1:2000,
Vector Laboratories) in PBST at RT (60 min). After
extensive washing with PBST, sections were developed
in a solution containing 0.05% 3’3-diaminobenzidine tet-
rahydrochloride (DAB, Sigma), 0.06% NiSO4 and 0.005%
glucose oxidase [26,34].
Relative DRG Somatic Count
The relative number of retrograde labelled FB
+ DRG
neurons was obtained by serially counting every fourth
section from the ipsilateral and contralateral L4 DRG
(total of 5 sections/animal, n = 10). This method of
counting allowed for the relative estimation of FB
labelled cell bodies and to avoid the possibility of double
counting, only those neurons with visible nuclei were
counted [35,36]. Note that in all instances, FB
+ neurons
were considered regenerated neurons [24].
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The number of BDA-labelled fibres was counted at both
stumps of the spinal cord including the lesion epicentre
(0 mm) and 1 mm rostral and caudal. As we have pre-
viously described [37], the axon index was calculated as
a percentage of every fourth section (total of 10 sec-
tions/animal, n = 6). Note that no BDA-labelled fibres
were found rostrally and/or at the epicentre in lipo-
some-treated animals.
Cellular Quantification Method
Due to the complexity in identifying individual popula-
tions of macrophage cells (CD68
+) and astrocytes
(GFAP
+) present in the spinal cord after injury, we
determined the percentage area fraction of the section
occupied by these stained structures [31,38,39]. Briefly,
using ImageJ (image processing program, NIH version
1.37) 20× (697.68 × 522.72 μm) magnification images
immunostained against the aforementioned antibodies
were converted to binary contrast images (black and
white). This provided a threshold by subtracting back-
ground levels from the immunoreactive stained areas
and allowed the determination of the percentage area
fraction per image to be collected, tabulated and statisti-
cally analysed [22,38,40,41].
Sandwich BDNF ELISA Test
According to manufacturer’s instructions (Millipore.
com), serum samples collected at the end of the experi-
mental period were analysed for BDNF concentration
level using an ELISA kit. Briefly, samples were incubated
overnight at 2-4°C in BDNF ELISA plates pre-coated
with rabbit anti-human BDNF polyclonal antibody.
After incubation, plates were thoroughly washed and
incubated at RT (2-3 hrs) with a biotinylated mouse
anti-human BDNF monoclonal antibody (1:1000). Plates
were then washed and incubated at RT (60 min) with a
streptavidin-HRP conjugate (1:1000), washed again,
developed with a TMB/E substrate at RT (15 min). The
optical density (OD) was measured at 450 nm and
plotted on a standard curve.
Statistics
In all graphs, columns represent an averaged mean (n =
10 and/or as specified per figure) and error bars indicate
standard error of mean (+/- S.E.). Comparisons between
groups were made using an independent samples t-test.
Results were considered significant if P < 0.05.
Results
Effectiveness of Macrophage Depletion
IHC analysis of spleen sections immunostained to detect
macrophage cells (CD68
+)w e r eu s e dt od e t e r m i n et h e
efficacy of macrophage depletion using clodronate
liposomes [22]. Our results revealed a significant differ-
ence in macrophage numbers during liposome treatment
(1 week after first injection), indicative of successful cel-
lular depletion (P < 0.0001; Figure 1A-B &1I). Spleens
tested 2 weeks after liposome treatment completion
showed early signs of macrophage repopulation evident
by CD68
+ immunoreactivity in spleens (Figure 1C-D
&1I). However, macrophage numbers had not reached
normal levels (P < 0.05; Fig. 1I). Comparatively, at the
end of the experimental period (day 35) we found a
complete repopulation of macrophage cells in spleens of
liposome-treated animals, as compared to untreated
naïve spleens (Figure 1E-H &1I).
Retrograde Tracing in DRG
Quantification of retrograde labelled FB
+ neurons in the
ipsilateral L4 DRG revealed some interesting variations
between test and control groups. Consistent with pre-
vious observations [7], our results indicated positive ret-
rograde labelling only in the ipsilateral DRG of saline-
treated control animals (white arrows, Figure 2A-B), as
compared to neurons in the contralateral DRGs (Figure
2C). However, no FB
+ labelled cell bodies were found in
the ipsilateral and contralateral DRGs of liposome-trea-
ted animals (red arrows, Figure 2D-F). Statistically, the
presence of FB
+ labelled neurons in the control group
as compared to unlabelled DRG neurons in the lipo-
some-treated group indicated a lack of retrograde label-
ling in the latter group (P < 0.001; Figure 2G). These
results are indicative of poor attempts at axonal regen-
eration, possibly attributable to the effects of liposome
administration and temporal depletion of macrophage
cells.
It seems unlikely that tracer leakage could have
affected retrograde labelling of DRG neurons in all of
the liposome-treated animals given that this would have
resulted in labelled cell bodies in both ipsilateral and
contralateral DRG, which was not found (Figure 2G).
Note that in all instances, the contralateral DRG was
used as the control (uninjured) side. The possibility that
regenerated fibres could still be present in the spinal
cord of liposome-treated animals was further explored
using anterograde tracing.
Anterograde Tracing in Spinal Cord
Normally in the pre-conditioned lesion model, regener-
ated ascending afferent fibres extend through the dorsal
column of the spinal cord [7]. Here, we assessed this by
anterograde BDA labelling of fibres in the dorsal column
of the injured spinal cord. Results from saline-treated
control animals demonstrated the presence of ascending
afferent fibres extending rostrally from the distal stump,
across the DCC and into the rostral stump (Figure 3A-
H). Quantification of BDA-labelled fibres 1 mm caudal
Aguilar Salegio et al. BMC Neuroscience 2011, 12:11
http://www.biomedcentral.com/1471-2202/12/11
Page 5 of 13revealed similar number of ascending fibres close to site
of injury in both experimental groups, however, no
regenerated fibres were found in liposome-treated ani-
mals at the lesion epicentre and 1 mm rostral
(P < 0.0001; Figure 3H&Figure 4). Evidently, in the lipo-
some-treated group labelled fibres in the dorsal column
halted at the site of lesion and did not cross the SCI
epicentre (Figure 4A-G). Higher magnification images of
BDA-labelled fibres in the caudal stump, revealed fibre
retraction and collapse close to the site of injury, with
no ascending fibres found in the rostral stump (Figure
4C). The lack of regenerated fibres across the SCI epi-
centre was consistent with the absence of retrograde
labelled FB
+ DRG neurons within this group. This find-
ing confirmed previous assumptions relating to abortive
attempts at axonal regeneration and offers tangible
explanations for the role of macrophage cells in the pre-
conditioned model of injury.
Figure 1 Confirmation of Macrophage Cell Depletion Examined in the Spleens of Liposome-Treated Animals. A-B) 1 week after liposome
administration no macrophage cells were present in the spleens of treated animals, as confirmed by the absence of CD68 (macrophage marker)
immunoreactivity (***P < 0.0001; I). C-D) By 2 week after liposome treatment completion, macrophage cells (CD68
+) had already began to
repopulate in the spleen of treated animals (*P < 0.05; I). E-F) At the end of the experimental period (day 35) macrophage numbers in the
spleen of treated animals had returned to normal levels, as compared to untreated animals (G-H). I) Quantification of immunoreactive CD68
+
cells as shown in panels A-H, demonstrated a significant cellular reduction during liposome administration and during repopulation 2 weeks
after treatment completion. No differences in macrophage cells were found at the end of the study. Columns represent an averaged mean (5
sections per animal, n = 5) and error bars indicate error of mean (+/- S.E.). Scale bars A, C, E, G 500 μm, enlarged views B, D, F, H 200 μm.
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+ DRG Neurons Found in Liposome-Treated Animals. A-B) In the ipsilateral DRG, only saline-treated control
animals showed retrograde labelled FB
+ neuronal cell bodies (white arrows), as compared to the contralateral DRG (C). D-E) No FB labelled
neurons were found in any of the liposome-treated animals, in the ipsilateral (red arrows) or contralateral DRG (F). G) Quantification of FB
+ cell
bodies in ipsilateral (black bar) and contralateral (white bar) DRGs revealed significantly more labelled neurons in saline-treated animals, as
compared to unlabelled DRG neurons in liposome-treated (***P < 0.0001). Note that the contralateral DRG was used from the uninjured side as
a control. Columns represent an averaged mean (5 sections per animal, n = 10) and error bars indicate error of mean (+/- S.E.). FB = fast blue
tracer, DRG = dorsal root ganglia, CL = contralateral, IL = ipsilateral. Scale bars A and D 500 μm, C and F 300 enlarged views 200 μm.
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Page 7 of 13Figure 3 Anterograde BDA-Labelled Fibres in the Spinal Cord of Saline-Treated Animals. A) M o n t a g eo fS C Ie p i c e n t r e( b l a c ka s t e r i s k )
demonstrating extensive anterograde labelling of ascending fibres in both proximal and distal stumps of the injured spinal cord (black arrows).
B-G) Higher magnification images confirming the presence of BDA-labelled fibres extending across both stumps (black arrows), consistent with
previous retrograde labelled results described in Figure 2. H) Quantification of percentage of BDA-labelled fibres revealed the presence of
regenerated ascending fibres found 1 mm rostral and at the injury epicentre (0 mm) in control animals only (***P < 0.0001). Similar number of
labelled fibres was found 1 mm caudal in the spinal cord of control and liposome-treated animals. BDA = biotinylated dextran amine, DCC =
dorsal column cut. Directional key: D = dorsal, V = ventral, C = caudal, R = rostral. Scale bars montage 800 μm (horizontal bar) and 1 mm
(vertical bar), B -E 200 μm, F-G enlarged views 100 μm.
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Page 8 of 13Figure 4 Anterograde BDA-Labelled Fibres in the Spinal Cord of Liposome-Treated Animals. A) Histology-processed section through the
SCI epicentre (black asterisk) revealed extent of lesioning through the dorsal columns (dashed line; shown as insert in panel B). B) Montage of
lesion site (black asterisk) demonstrating anterograde BDA-labelled fibres present only in the distal stump of the spinal cord (D), with no visible
fibres found in the proximal stump (C). E-G) Closer observation distally revealed extensive neuronal collapse and retraction of BDA-labelled fibres
evident by their bulb-like structure (black arrows). BDA = biotinylated dextran amine, DCC = dorsal column cut. Directional key: D = dorsal, V =
ventral, C = caudal, R = rostral. Scale bars, A (horizontal bar) 500 μm and (vertical bar) 1 mm, montage B 800 μm, C-E 200 μm, F-G enlarged
views 100 μm.
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Macrophage quantification at 1-2 mm both rostral and
caudal from the SCI epicentre revealed greater macro-
phage numbers (CD68
+) in the saline-treated group, as
compared to the liposome-treated group 4 weeks after
CNS lesion (P < 0.05 & P < 0.01, respectively;
Figure 5A). No statistically significant difference in
macrophage numbers between these two groups was
found at the SCI epicentre. Similarly, astrocyte quantifi-
cation (GFAP
+) 3 mm caudal from the lesion site
reached similar levels with no statistical differences
found between both groups (Figure 5B). Conversely, 3
mm rostral from the lesion site we found a significantly
higher astrocyte expression (GFAP
+) in liposome-treated
animals as compared to controls (P < 0.05).
BDNF ELISA Serum Levels
Calculated serum levels from both treatment groups
revealed a significantly higher BDNF concentration level
in control animals than in liposome-treated (P < 0.05;
Figure 6). The fact that immune cells, such as macro-
phage cells have been reported to support neurite out-
growth by secreting neurotrophic factors such as BDNF
[15,42,43], provide a plausible explanation for the lack
of regenerated fibres in liposome-treated animals.
Discussion
Effects of Macrophage Depletion
The conditioning SNI normally supports the regenera-
tion of CNS afferent fibres of adult DRG neurons [7].
However, we found that the temporal depletion of
macrophage cells during the conditioning phase of DRG
neurons, consequently abolished the regenerative com-
petence of injured CNS fibres.
Comparisons between injury-matched control and
liposome-treated animals revealed a considerable lack of
regeneration in the latter group, when compared to ret-
rogradely labelled FB
+ DRG neurons found in control
animals. Concomitantly, anterograde tracing of ascend-
ing CNS fibres demonstrated extensive axonal collapse
and retraction by the formation of bulb-like structures
at the end of axons in liposome-treated animals. In con-
trast, lengthy BDA-labelled afferent fibres were found in
the proximal stump of saline-treated control animals. In
addition, astrocyte quantification in liposome-treated
animals revealed a higher astrocytic expression level ros-
tral to the spinal cord lesion. This level of astrocyte
expression most likely represents the amount of glial
scar formation (refer to additional file 1), which may be
associated with the observed axonal collapse, as it forms
an inhibitory barrier against axonal regrowth [44-46].
Furthermore, macrophage quantification revealed
greater numbers in control animals, specifically in
regions rostral and caudal to the lesion, as compared to
liposome-treated animals. Note that, we do not attribute
this variation in macrophage numbers solely to the
depletion of these cells, given that: (i) spleens of lipo-
some-treated animals showed macrophage repopulation
returned to normal levels; and (ii) liposomal treatment
was only temporarily administered, allowing sufficient
time for macrophage cells to infiltrate the CNS lesion.
This suggests that macrophage presence during the con-
ditioning phase following SNI, is critical for the early
activation and guidance of these cells into the CNS
compartment [17].
Moreover, BDNF analysis of blood samples demon-
strated elevated serum concentration levels in control
animals. This difference in endogenous BDNF availabil-
ity, at least for injured peripheral nerves has been
demonstrated to support axonal regeneration and myeli-
nation following trauma [47], and is likely to be also
contributing to the regeneration of ascending afferent
fibres [24]. Certainly, injury to the peripheral DRG
branch may be stimulating macrophage cells with a phe-
notype beneficial for CNS regeneration, as demonstrated
using peripheral nerve fragments, reported to enhance
phagocytosis and secretion of BDNF [48,49]. BDNF is
also a nerve trophic factor recently confirmed by our
laboratory to be synthesized by macrophages [19] and is
a potential mechanistic factor in the successful regenera-
tion of matured CNS neurons after a pre-conditioned
lesion (Figure 7).
Macrophage Contribution
The recruitment number and the phagocytic activity of
macrophages has been previously shown to improve the
clearance of myelin debris [50], as well as provide
important signaling molecules for the improved regen-
eration of injured axons, dependant on the timing of
macrophage activation [51]. This is important given that
myelin clearance during Wallerian degeneration by
macrophage cells has been reported to be one of the
major differences between the PNS and the CNS
[52,53]. It is also noteworthy that SNI induces circulat-
ing macrophage cell infiltration into the uninjured spinal
cord, where these cells proliferated and differentiated
into microglia cells [17]. This highlights another inter-
esting factor in relation to immune surveillance into the
uninjured CNS compartment as it introduces new func-
tions in “bi-directional communication between the
CNS and immune system” [54]. Mechanistically, we
believe the regenerative trigger characteristic of this
model illustrates a complex neuroimmune interaction
between the peripheral and central nervous system,
regardless of the immune privileged status of the CNS
[55,56].
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Despite of the controversy of macrophage cells in CNS
r e p a i r[ 5 7 , 5 8 ] ,h e r ew ea s c r i b eab e n e f i c i a lr o l ef o r
inflammatory cells in CNS regeneration, given that in
vivo macrophage depletion led to astrocyte up-regula-
tion, reduced macrophage infiltration into the CNS and
a down-regulation in endogenous BDNF serum concen-
tration. Our data suggest that macrophage activation
might be playing a role in the conditioning effect on the
regeneration of DRG neurons. These cells are highly
Figure 5 Macrophage and Astrocyte Quantification in the
Injured Spinal Cord. A) Statistical analysis of macrophage numbers
in the spinal cord of both treatment groups indicated a greater
macrophage presence in control animals than in liposome-treated.
Specifically, in control animals these numbers were significantly
higher 1-2 mm both rostral and caudal from the SCI epicentre, as
compared to liposome-treated animals (*P < 0.05, **P < 0.01,
respectively), while no differences were found at the SCI epicentre.
B) Astrocyte quantification 3 mm rostral from the lesion epicentre
revealed a greater reduction in astrocyte activation in control
animals (*P < 0.05). No differences were observed between groups
caudally. Columns represent an averaged mean (n = 10) and error
bars indicate error of mean (+/- S.E.).
Figure 6 Higher BDNF Concentration Serum Levels in Saline-
Treated Controls. Analysis of serum trophic levels at the end of
the experimental period revealed an increased BDNF serum
concentration in saline-treated controls, as compared to liposome-
treated animals (*P < 0.05). Columns represent an averaged mean
(n = 10) and error bars indicate error of mean (+/- S.E.). BDNF =
brain derived neurotrophic factor.
Figure 7 Proposed Mechanistic Model for the Regeneration of Ascending Fibres in Pre-Conditioned DRG Neurons. Regenerative
competence of pre-conditioned DRG neurons is described as a multi-faceted cascade of events: (1-2) SNI results in DRG and macrophage
activation, upregulation of BDNF, cAMP and regeneration-associated genes (RAGs); all contributing to the beneficial phenotypic ‘priming’ of
macrophage cells. (3) Facilitated entry of primed macrophage cells into the CNS compartment prior to CNS lesion. (4) SCI resulting in axonal
injury, axon-myelin breakdown associated with the process of Wallerian degeneration. (5-6) Efficient removal of axonal and myelin debris by
BDNF expressing macrophages beneficially activated with enhanced phagocytic capabilities, (7) consequently leading to axonal regeneration of
the injured CNS-DRG branch. BNB = blood nerve barrier, RAGs = regeneration-associated genes, BBB = brain-blood barrier.
Aguilar Salegio et al. BMC Neuroscience 2011, 12:11
http://www.biomedcentral.com/1471-2202/12/11
Page 11 of 13attractive for promoting CNS repair, as long as the pro-
regenerative process is not coupled to undesired
inflammation.
Additional material
Additional file 1: Glial Scar Formation at Spinal Cord Injury
Epicentre. Montage of the spinal cord lesion epicentre demonstrating
the extent of glial scar formation after the injury to the dorsal columns.
Immunoreactive GFAP
+ staining identifies the location of lesion epicentre
(yellow asterisk), validates the paradigm for astrocyte quantification and
delineates the presence of the physical/biochemical barrier against
axonal regeneration in the matured CNS (dashed line). Scale bars
montage 500 μm.
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